Real-world (RW) treatment (Tx) patterns and clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC): Results of a nationwide, longitudinal, retrospective study in Hungary

被引：0
|
作者：
Maraz, A. C. [1 ]
Nagy, B. [2 ]
Macher, T. [2 ]
Jesko, J. [2 ]
Tischler, E. [3 ]
Csongvai, C. [4 ]
Kearney, M. [5 ]
机构：
[1] Univ Szeged, Dept Oncotherapy, Szeged, Hungary
[2] Healthware Consulting Ltd, Budapest, Hungary
[3] Merck Kft, Market Access, Budapest, Hungary
[4] Merck Kft, Med Affairs, Budapest, Hungary
[5] Merck Healthcare KGaA, Global Evidence & Value Dev, Darmstadt, Germany
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1834
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1756P
引用
收藏
页码：S1341 / S1341
页数：1
相关论文
共 50 条
  • [21] The evolution of treatment patterns in patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) and clinical outcomes: Results of a longitudinal observational cohort study in England
    Mahmoudpour, Seyed Hamidreza
    Knott, Craig
    Kearney, Mairead
    Boutmy, Emmanuelle
    Verpillat, Patrice
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Real-World Treatment Patterns and Clinical Outcomes in Patients With Locally Advanced or Metastatic Urothelial Carcinoma by Eligibility for Maintenance Avelumab
    Morgans, Alicia K.
    Sonpavde, Guru P.
    Shih, Vanessa
    Wright, Phoebe
    Hepp, Zsolt
    Willmon, Candice L.
    Chang, Nancy N.
    Mucha, Lisa
    Naga, Sai Sriteja Boppudi
    Powles, Thomas
    CLINICAL GENITOURINARY CANCER, 2024, 23 (01)
  • [23] Real-world (rw) treatment patterns, sequencing, and outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in the US.
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie A.
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Rey, Gabriel Gomez
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 605 - 605
  • [24] Patterns of metastases, treatment (tx), and outcomes in bone predominant (BP) metastatic urothelial carcinoma (mUC).
    Nelson, Ariel Ann
    Opneja, Aman
    Nezami, Behtash Ghazi
    Ponsky, Lee Evan
    Wright, Matthew David
    Mergler, Patrick
    Kyasaram, Ravi Kumar
    Eitman, Cheryl
    Patel, Krupen
    MacLennan, Gregory
    Cooney, Matthew M.
    Grivas, Petros
    Barata, Pedro C.
    Garcia, Jorge A.
    Fu, Pingfu
    Hoimes, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] Treatment patterns, indicators of receiving systemic treatment, and clinical outcomes in metastatic urothelial carcinoma: A retrospective analysis of real-world data in Germany.
    Niegisch, Guenter
    Grimm, Marc-Oliver
    Hardtstock, Fraence
    Krieger, Julia
    Starry, Alexandra
    Osowski, Ulrike
    Guenther, Silke
    Deiters, Barthold
    Maywald, Ulf
    Wilke, Thomas
    Kearney, Mairead
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [26] Effect of type of antibiotics (Abx) on outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial carcinoma (mUC) in a real-world setting
    Hobeika, Charbel
    Dawsey, Scott
    Patgunarajah, Ubenthira
    Lynn, David
    Pramod, Nikhil
    Wei, Wei
    Nair, Monica
    Maroli, Kimberly
    Martin, Allison
    Ornstein, Moshe Chaim
    Wee, Christopher Eing
    Gilligan, Timothy D.
    Nizam, Amanda
    Bonham, Amanda
    Mian, Omar Y.
    Pavicic, Paul G.
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 640 - 640
  • [27] Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States
    Geynisman, Daniel M.
    Broughton, Edward
    Hao, Yi
    Zhang, Ying
    Le, Trong
    Huo, Stephen
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (05) : 195.e1 - 195.e11
  • [28] Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan
    Kita, Yuki
    Otsuka, Hikari
    Ito, Katsuhiro
    Hara, Takuto
    Shimura, Soichiro
    Kawahara, Takashi
    Kato, Minoru
    Kanamaru, Sojun
    Inoue, Koji
    Ito, Hiroki
    Igarashi, Atsushi
    Sazuka, Tomokazu
    Takamatsu, Dai
    Hashimoto, Kohei
    Abe, Takashige
    Naito, Sei
    Matsui, Yoshiyuki
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    Kobayashi, Takashi
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (05) : 552 - 559
  • [29] Real-world (RW) systemic treatment patterns and clinical outcomes in locally advanced (LA) and recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC) patients (pts).
    Thao Vo
    Boyd, Marley
    Espirito, Janet L.
    Gumuscu, Burak
    Chirovsky, Diana Romana
    Robert, Nicholas J.
    Swaby, Ramona F.
    Zhou, Wei
    Cowey, Charles Lance
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Real-world (RW) clinical outcomes for metastatic renal cell carcinoma (mRCC)
    George, S.
    Faccone, J.
    Huo, S.
    Zhang, Y.
    Stwalley, B.
    Hamilton, M.
    Le, T. K.
    Ejzykowicz, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S701 - S702
12345